<DOC>
	<DOCNO>NCT00316082</DOCNO>
	<brief_summary>The purpose trial understand saxagliptin effective placebo treatment type 2 diabetic subject control diet exercise</brief_summary>
	<brief_title>Study BMS-477118 Monotherapy With Titration Subjects With Type 2 Diabetes Who Are Not Controlled With Diet Exercise</brief_title>
	<detailed_description>All subject participate lead-in period , qualify subject continue short-term randomized treatment period . Subjects complete short-term period eligible enter long term extension period . Also , subject short-term period elevate blood sugar require additional medication blood sugar control eligible enter long-term treatment extension period receive metformin ( rescue medication ) add onto blind study medication</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes Inadequate blood sugar control Previous treatment diabetes Current treatment medication low blood sugar Major heart , liver kidney problem Women pregnant breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>77 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>